Coloplast Affirms FY2026 Sales Guidance of $4.499B vs $4.420B Est
Coloplast (OTC:CLPBY) affirms FY2026 sales outlook from $4.499 billion to $4.499 billion vs $4.420 billion estimate.
Coloplast said its sales next year will be about $4.5 billion, which is a little higher than what other people guessed. When a company sticks with its own plan and beats what others expected, it can mean the company feels confident about its business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.